Gary B. Chapman, Ph.D.

Shareholder

Gary B. Chapman, Ph.D.

Overview

Dr. Chapman is a patent attorney whose practice focuses on intellectual property strategy, portfolio development and management, and counseling in strategic business planning relating to technology commercialization. Dr. Chapman’s experience includes complex technologies arising out of the intersection of life sciences, physics and chemistry such as from multi-disciplinary fields including biomedical engineering, biophysics and chemical engineering. Dr. Chapman’s technical experience includes medical devices, tissue implants, tissue engineering, microbiology, medical diagnostics, research tools, personalized medicine, pharmaceuticals, fluidics, optics, imaging, microelectromechanical systems (MEMS), nanotechnology, semiconductors, renewable energy, oil and gas production processes, instruments and components.

Read More

Dr. Chapmanā€™s practice encompasses a broad range of clients, such as major research and academic institutions, start-ups, and mid-size to Fortune 500 companies. He works to evaluate and develop a comprehensive intellectual property strategy to assist his clients in achieving their business goals. Examples include developing, commercializing and enforcing intellectual property rights including by transactional agreements, landscape assessments, freedom to operate opinions, infringement opinions and patentability evaluation. Dr. Chapman has represented clients in various administrative proceedings at the United States Patent and Trademark Office.

 

Prior to law school, Dr. Chapman was a Research Associate in the Department of Bioengineering at Rice University and the Department of Medicine at Baylor College of Medicine. He obtained a Ph.D. in the Department of Biophysics from the University of Rochester School of Medicine and Dentistry and a B.Sc. from the University of Western Ontario in Medical Biophysics. His research experience includes developing instrumentation for biological applications and conducting research in cardiovascular medicine, microfluidics, and modeling of biological systems. Dr. Chapman’s diverse background is an asset in working with clients over a wide range of technological areas, including interacting with inventors and business leaders to develop, leverage and maximize intellectual property rights across a range of technologies.

Prior to joining the firm, Dr. Chapman was a patent attorney at Lathrop & Gage.

Education

  • University of Colorado School of Law, J.D., 2004
  • University of Rochester, Ph.D. in Biophysics, 1997
  • University of Western Ontario, B.S. in Medical Biophysics, 1992

Admissions

  • Registered to practice before the U.S. Patent and Trademark Office
  • Colorado

Honors

  • Order of the Coif
  • Articles Editor, Journal on Telecommunications & High Technology Law, University of Colorado
  • Leon and Dora Wolf Scholarship, University of Colorado
  • Samuel and Frances Dazzo Scholarship, University of Colorado
  • William F. Neumann Award for Outstanding Biophysics Student, University of Rochester
  • Dean’s Honor List, University of Western Ontario

Professional Affiliations

  • American Bar Association
  • Colorado Bar Association
  • American Intellectual Property Law Association (AIPLA)

Articles, Publications & Lectures

  • “Entrepreneurialism Part II: Positioning Your Business for Success.” Colorado Bioscience Association BioBreakfast, Oct. 6, 2016, (moderated panel of attorneys discussing structured agreements for risk management and increasing successful outcomes for entrepreneurs in the life sciences industry)
  • “Entrepreneurialism in Colorado’s Life Science Industry.” Colorado Bioscience Association BioBreakfast, Oct. 28, 2015, (moderated a panel of Colorado biotechnology company representatives regarding emerging company successes)
  • “Riding the Bull: Optimizing the License Relationship.” AUTM 2015 Western Region Meeting. Calgary, Alberta Canada, Sept. 10-11, 2015
  • “Aftermath of Alice Corp. v. CLS Bank International: Takeaways from the Compusphere.” 13th Annual Rocky Mountain Intellectual Property & Technology Institute, May 28-29, 2015
  • Gary B. Chapman. “Protecting Trademarks Worldwide: International Trademark Filing Strategies.” In Trademark Practice Forms Volume 1. Thomson/Reuters/West 2012.
  • Liu, X, G.B. Chapman, K.J. Peyton, A.I. Schafer, W. Durante. “Antiapoptotic action of carbon monoxide on cultured vascular smooth muscle cells.” Exp. Biol. Med. 228(5), 572-575, 2003.
  • Liu, X, G.B. Chapman, K.J. Peyton, A.I. Schafer, W. Durante. “Carbon monoxide inhibits apoptosis in vascular smooth muscle cells.” Cardiovascular Research, 55(2), 396-405, 2002.
  • Peyton, K.J., S.V. Reyna, G.B. Chapman, D. Ensenat, X. Liu, H. Wang, A.I. Schafer and W. Durante. “Heme oxygenase-1 derived carbon monoxide is an autocrine inhibitor of vascular smooth muscle cell growth.” Blood 99(12), 4443-48, 2002.
  • Wang H., X Jiang, F. Yang, G.B. Chapman, W. Durante, N.E. Sibinga, A.I. Schafer. “Cyclin A transcriptional suppression is the major mechanism mediating homocysteine-induced endothelial cell growth inhibition.” Blood, 99(3), 939-45, 2002.
  • Liu, X-M, G.B. Chapman, Wang H. and W. Durante. “Adenovirusmediated heme oxygenase-1 gene expression stimulates apoptosis in vascular smooth muscle cells.” Circulation, 105(1), 79-84, 2002.
  • Tulis, D.A., W. Durante, K.J. Peyton, G.B. Chapman, A.J. Evans and A.I. Schafer. “YC-1 stimulates endogenous cGMP and inhibits injury-induced neointima formation in rat carotid arteries.” Biochemical Biophysical Research Communications, 279(2), 646-52, 2000.
  • Chapman, G.B., W. Durante, J.D. Hellums and A.I. Schafer. “Physiological cyclic stretch causes cell cycle arrest in cultured vascular smooth muscle cells.” American Journal of Physiology: Frame, M.S., G.B. Chapman, Y. Makino and I.H. Sarelius. “Shear stress gradient over endothelial cells in a curved microchannel system.” Biorheology 35(4, 5), 245-261, 1998.
  • Chapman, G.B. and G.R. Cokelet, “Flow resistance and drag forces due to multiple adherent leukocytes in post-capillary vessels.” Biophysical Journal 74(1), 3292-3301, 1998.
  • Chapman, G.B. and G.R. Cokelet, “Model studies of leukocyteendothelium- blood interactions. II Hemodynamic impact of leukocytes adherent to the wall of post-capillary vessels.”
  • Biorheology 34(1), 37-56, 1997. Chapman, G.B. and G.R. Cokelet, “Model studies of leukocyteendothelium-blood interactions. I Drag force on an adherent leukocyte.” Biorheology 33(2), 119-138, 1996.

Education

  • University of Colorado School of Law, J.D., 2004
  • University of Rochester, Ph.D. in Biophysics, 1997
  • University of Western Ontario, B.S. in Medical Biophysics, 1992

Admissions

  • Registered to practice before the U.S. Patent and Trademark Office
  • Colorado